share_log

4: Statement of changes in beneficial ownership of securities-Director Intrater James

4: Statement of changes in beneficial ownership of securities-Director Intrater James

4:持股變動聲明-董事 Intrater James
美股SEC公告 ·  01/15 22:03

牛牛AI助理已提取核心訊息

Cardio Diagnostics Holdings has disclosed a future securities transaction notification involving James Intrater, scheduled for December 31, 2024. The filing indicates a pending transaction, though specific details regarding the nature, volume, and value of the securities involved have not been provided.The reporting person's address is listed as C/O Cardio Diagnostics Holdings Inc., located in Chicago, Illinois. The transaction appears to be preliminary in nature, with execution details yet to be determined.
Cardio Diagnostics Holdings has disclosed a future securities transaction notification involving James Intrater, scheduled for December 31, 2024. The filing indicates a pending transaction, though specific details regarding the nature, volume, and value of the securities involved have not been provided.The reporting person's address is listed as C/O Cardio Diagnostics Holdings Inc., located in Chicago, Illinois. The transaction appears to be preliminary in nature, with execution details yet to be determined.
Cardio Diagnostics Holdings已披露一項涉及James Intrater的未來證券交易通知,計劃於2024年12月31日進行。該文件指出有一項待定交易,但未提供涉及證券的性質、成交量和價值的具體細節。報告人的地址列爲C/O Cardio Diagnostics Holdings Inc.,位於伊利諾伊州芝加哥。該交易似乎是初步性質,具體執行細節尚待確定。
Cardio Diagnostics Holdings已披露一項涉及James Intrater的未來證券交易通知,計劃於2024年12月31日進行。該文件指出有一項待定交易,但未提供涉及證券的性質、成交量和價值的具體細節。報告人的地址列爲C/O Cardio Diagnostics Holdings Inc.,位於伊利諾伊州芝加哥。該交易似乎是初步性質,具體執行細節尚待確定。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 405

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。